AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

MeVis Medical Solutions AG

Report Publication Announcement Oct 10, 2024

287_rns_2024-10-10_fa0d77e4-5f9e-4860-8cb8-44a91ee30314.html

Report Publication Announcement

Open in Viewer

Opens in native device viewer

News Details

Advance Financial Reports | 10 October 2024 11:37

MeVis Medical Solutions AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

MeVis Medical Solutions AG / Preliminary announcement on the disclosure of financial statements

MeVis Medical Solutions AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

10.10.2024 / 11:37 CET/CEST

Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] transmitted by EQS News – a service of EQS Group AG.

The issuer is solely responsible for the content of this announcement.

MeVis Medical Solutions AG hereby announces that the following financial reports shall be disclosed:

Report Type: Annual financial report

Language: German

Date of disclosure: January 30, 2025

Address: https://www.mevis.de/investor-relations/finanzberichte

Report Type: Financial report (half-year/Q2)

Language: German

Date of disclosure: May 27, 2025

Address: https://www.mevis.de/investor-relations/finanzberichte


10.10.2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Archive at www.eqs-news.com


Language: English
Company: MeVis Medical Solutions AG
Caroline-Herschel-Str. 1
28359 Bremen
Germany
Internet: http://www.mevis.de
End of News EQS News Service

show this

Talk to a Data Expert

Have a question? We'll get back to you promptly.